Annual CFI
$9.46 M
+$19.20 M+197.14%
31 December 2023
Summary:
Immunic annual cash flow from investing activities is currently $9.46 million, with the most recent change of +$19.20 million (+197.14%) on 31 December 2023. During the last 3 years, it has risen by +$9.61 million (+6580.82%). IMUX annual CFI is now -20.55% below its all-time high of $11.91 million, reached on 31 December 2013.IMUX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$50.00 K
+$130.00 K+72.22%
30 September 2024
Summary:
Immunic quarterly cash flow from investing activities is currently -$50.00 thousand, with the most recent change of +$130.00 thousand (+72.22%) on 30 September 2024. Over the past year, it has dropped by -$6000.00 (-13.64%). IMUX quarterly CFI is now -100.54% below its all-time high of $9.33 million, reached on 30 June 2019.IMUX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$426.00 K
-$6000.00-1.43%
30 September 2024
Summary:
Immunic TTM cash flow from investing activities is currently -$426.00 thousand, with the most recent change of -$6000.00 (-1.43%) on 30 September 2024. Over the past year, it has dropped by -$425.00 thousand (-42500.00%). IMUX TTM CFI is now -103.43% below its all-time high of $12.43 million, reached on 30 September 2013.IMUX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMUX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +197.1% | -13.6% | -10000.0% |
| 3 y3 years | +6580.8% | -150.0% | -491.7% |
| 5 y5 years | +2380.0% | -104.0% | -104.0% |
IMUX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +197.1% | -100.9% | +99.5% | -104.5% | +95.6% |
| 5 y | 5 years | -10.2% | +197.1% | -100.9% | +99.5% | -104.0% | +95.6% |
| alltime | all time | -20.6% | +164.9% | -100.5% | +99.5% | -103.4% | +95.6% |
Immunic Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$50.00 K(-72.2%) | -$426.00 K(+1.4%) |
| June 2024 | - | -$180.00 K(+480.6%) | -$420.00 K(-110.3%) |
| Mar 2024 | - | -$31.00 K(-81.2%) | $4.10 M(-56.7%) |
| Dec 2023 | $9.46 M(-197.1%) | -$165.00 K(+275.0%) | $9.46 M(<-9900.0%) |
| Sept 2023 | - | -$44.00 K(-101.0%) | -$1000.00(-96.7%) |
| June 2023 | - | $4.34 M(-18.7%) | -$30.00 K(-99.3%) |
| Mar 2023 | - | $5.33 M(-155.4%) | -$4.39 M(-54.9%) |
| Dec 2022 | -$9.74 M(>+9900.0%) | -$9.63 M(>+9900.0%) | -$9.74 M(+7279.5%) |
| Sept 2022 | - | -$73.00 K(+160.7%) | -$132.00 K(+67.1%) |
| June 2022 | - | -$28.00 K(+133.3%) | -$79.00 K(+14.5%) |
| Mar 2022 | - | -$12.00 K(-36.8%) | -$69.00 K(+3.0%) |
| Dec 2021 | -$67.00 K(-54.1%) | -$19.00 K(-5.0%) | -$67.00 K(-6.9%) |
| Sept 2021 | - | -$20.00 K(+11.1%) | -$72.00 K(-37.4%) |
| June 2021 | - | -$18.00 K(+80.0%) | -$115.00 K(-24.3%) |
| Mar 2021 | - | -$10.00 K(-58.3%) | -$152.00 K(+4.1%) |
| Dec 2020 | -$146.00 K(-101.4%) | -$24.00 K(-61.9%) | -$146.00 K(-0.7%) |
| Sept 2020 | - | -$63.00 K(+14.5%) | -$147.00 K(-112.7%) |
| June 2020 | - | -$55.00 K(+1275.0%) | $1.15 M(-89.1%) |
| Mar 2020 | - | -$4000.00(-84.0%) | $10.54 M(+0.0%) |
| Dec 2019 | $10.54 M(-2638.8%) | -$25.00 K(-102.0%) | $10.54 M(-1.9%) |
| Sept 2019 | - | $1.24 M(-86.7%) | $10.74 M(+16.2%) |
| June 2019 | - | $9.33 M(<-9900.0%) | $9.24 M(-3497.4%) |
| Mar 2019 | - | -$7000.00(-103.9%) | -$272.00 K(-34.5%) |
| Dec 2018 | -$415.00 K | $180.00 K(-168.4%) | -$415.00 K(-41.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$263.00 K(+44.5%) | -$706.00 K(+15.4%) |
| June 2018 | - | -$182.00 K(+21.3%) | -$612.00 K(+9.9%) |
| Mar 2018 | - | -$150.00 K(+35.1%) | -$557.00 K(-17.8%) |
| Dec 2017 | -$678.00 K(+3128.6%) | -$111.00 K(-34.3%) | -$678.00 K(+1.5%) |
| Sept 2017 | - | -$169.00 K(+33.1%) | -$668.00 K(+21.5%) |
| June 2017 | - | -$127.00 K(-53.1%) | -$550.00 K(+44.0%) |
| Mar 2017 | - | -$271.00 K(+168.3%) | -$382.00 K(+1719.0%) |
| Dec 2016 | -$21.00 K(-98.4%) | -$101.00 K(+98.0%) | -$21.00 K(-103.7%) |
| Sept 2016 | - | -$51.00 K(-224.4%) | $568.00 K(-13.3%) |
| June 2016 | - | $41.00 K(-54.4%) | $655.00 K(-213.7%) |
| Mar 2016 | - | $90.00 K(-81.6%) | -$576.00 K(-55.0%) |
| Dec 2015 | -$1.28 M(-37.2%) | $488.00 K(+1255.6%) | -$1.28 M(-34.4%) |
| Sept 2015 | - | $36.00 K(-103.0%) | -$1.95 M(-22.8%) |
| June 2015 | - | -$1.19 M(+93.5%) | -$2.53 M(+40.3%) |
| Mar 2015 | - | -$615.00 K(+236.1%) | -$1.80 M(-11.7%) |
| Dec 2014 | -$2.04 M(-117.1%) | -$183.00 K(-66.2%) | -$2.04 M(-14.4%) |
| Sept 2014 | - | -$541.00 K(+16.8%) | -$2.38 M(-197.7%) |
| June 2014 | - | -$463.00 K(-45.7%) | $2.44 M(-65.9%) |
| Mar 2014 | - | -$853.00 K(+62.5%) | $7.14 M(-40.0%) |
| Dec 2013 | $11.91 M(-181.6%) | -$525.00 K(-112.3%) | $11.91 M(-4.2%) |
| Sept 2013 | - | $4.28 M(+0.9%) | $12.43 M(+52.5%) |
| June 2013 | - | $4.24 M(+8.3%) | $8.16 M(+108.3%) |
| Mar 2013 | - | $3.92 M | $3.92 M |
| Dec 2012 | -$14.59 M(>+9900.0%) | - | - |
| Dec 2011 | -$18.00 K | - | - |
FAQ
- What is Immunic annual cash flow from investing activities?
- What is the all time high annual CFI for Immunic?
- What is Immunic annual CFI year-on-year change?
- What is Immunic quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Immunic?
- What is Immunic quarterly CFI year-on-year change?
- What is Immunic TTM cash flow from investing activities?
- What is the all time high TTM CFI for Immunic?
- What is Immunic TTM CFI year-on-year change?
What is Immunic annual cash flow from investing activities?
The current annual CFI of IMUX is $9.46 M
What is the all time high annual CFI for Immunic?
Immunic all-time high annual cash flow from investing activities is $11.91 M
What is Immunic annual CFI year-on-year change?
Over the past year, IMUX annual cash flow from investing activities has changed by +$19.20 M (+197.14%)
What is Immunic quarterly cash flow from investing activities?
The current quarterly CFI of IMUX is -$50.00 K
What is the all time high quarterly CFI for Immunic?
Immunic all-time high quarterly cash flow from investing activities is $9.33 M
What is Immunic quarterly CFI year-on-year change?
Over the past year, IMUX quarterly cash flow from investing activities has changed by -$6000.00 (-13.64%)
What is Immunic TTM cash flow from investing activities?
The current TTM CFI of IMUX is -$426.00 K
What is the all time high TTM CFI for Immunic?
Immunic all-time high TTM cash flow from investing activities is $12.43 M
What is Immunic TTM CFI year-on-year change?
Over the past year, IMUX TTM cash flow from investing activities has changed by -$425.00 K (-42500.00%)